Downregulation of SLC27A2, encoding FATP2, reduced tumor burden, and exerted a synergistic effect in preventing tumor progression in different NB mouse models when combined with conventional chemotherapeutic drugs.99 This evidence concerns the gene SLC27A2 and neuroblastoma.